We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
AIXI | XIAO I Corporation | 1.94 | 1.14 | 141.35% | 659,320,848 |
HCAI | Huachen AI Parking Management Technology Holding Company Ltd | 0.3525 | 0.2058 | 140.29% | 488,957,597 |
QNCX | Quince Therapeutics Inc | 0.1611 | 0.0736 | 84.11% | 578,292,998 |
CETX | Cemtrex Inc | 1.29 | 0.4943 | 62.12% | 147,094,375 |
IPST | IP Strategy Holdings Inc | 0.386001 | 0.1439 | 59.44% | 147,664,873 |
MOVE | Corvex Inc | 12.13 | 4.52 | 59.33% | 1,054,550 |
HUBC | Hub Cyber Security Ltd | 0.1159 | 0.0419 | 56.62% | 274,239,268 |
CUPR | Cuprina Holdings Cayman Ltd | 0.594 | 0.1993 | 50.49% | 45,013,892 |
LNZA | LanzaTech Global Inc | 27.09 | 9.09 | 50.46% | 186,655 |
SILO | Silo Pharma Inc | 0.5212 | 0.1654 | 46.49% | 162,263,294 |
ADVB | Advanced Biomed Inc | 6.4601 | 2.04 | 46.16% | 14,632,604 |
Advancing AI-enabled chemical threat detection and dual-use biodefense technologies through initial commercial deploymentSACRAMENTO, Calif., April 7, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven drug discovery and biodefense company, today announced that its subsidiary, BioSymetrics, has entered into a revenue-generating, commercial defense-focused collaboration with a specialized biotechnology partner to support the development of an advanced AI-enabled platform for chemical threat assessment, with initial engagement underway and additional engagements currently under discussion.
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first patients in its NANOPULSE-AF study, a prospective, multicenter, IDE pivotal clinical investigation currently evaluating the nPulse™ Cardiac Catheter System for treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation (AF).
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions